Investor Transition Histories and the Timing of Follow-on Investor Entry in Early-Stage Healthcare Ventures
The study examines 744 early-stage healthcare ventures entering private financing between 2011–2024.
Company · 4 documents
The study examines 744 early-stage healthcare ventures entering private financing between 2011–2024.
An estimated 49.4% of new businesses close within their first five years, with financial strain and capital shortages accounting for 38% of venture failures.
The study analyzes a dataset of 808 technology unicorn acquisitions announced between 2010 and 2024, including 601 deals involving U.S.-based PE sponsors and 207 non-U.S. deals.
The visible angel investment market in Europe reached 1,220 Million Euros in 2024, reflecting a -2,8% decrease from 1,255 Million Euros in 2023.